Parallel Advisors’s VIVEVE MED INC VIVE Stock Holding History

Parallel Advisors’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1	Closed	-$6K	–	2111
2016 Q4	$6K	Buy	+1	New	+$5.95K	﹤0.01%	1327

Other funds holding VIVE

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

HighTower Advisors

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Alyeska Investment Group

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Parallel Advisors's VIVE Position: Q1 2017 in Review

Parallel Advisors sold out of VIVEVE MED INC (VIVE) in Q1 2017, closing a stake of 1 share — an estimated $6K sold.

Parallel Advisors first reported a position in VIVE in Q4 2016 and held it in 1 quarter. The position peaked at $6K in Q4 2016. 21 funds tracked by Wall St. Rank hold VIVE as of Q1 2017.

Parallel Advisors reported no remaining VIVEVE MED INC position as of Q1 2017 after selling out during the quarter.
Parallel Advisors sold 1 VIVEVE MED INC share in Q1 2017, an estimated $6K.
Parallel Advisors first reported a position in VIVEVE MED INC in Q4 2016 and held it in 1 quarter.
Parallel Advisors's VIVEVE MED INC position peaked at $6K in Q4 2016.
21 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2017.

Based on Parallel Advisors's 13F filing for Q1 2017, filed 12 May 2017.